Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.94
-0.04 (-0.50%)
Nov 21, 2024, 4:00 PM EST - Market closed

Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for TMCI stock have an average target of 7.40, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts a decrease of -6.80% from the current stock price of 7.94.

Analyst Consensus: Hold
Target Low Average Median High
Price $6.00 $7.40 $8.00 $8.00
Change -24.43% -6.80% +0.76% +0.76%

Analyst Ratings

The average analyst rating for TMCI stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 000000
Buy 000000
Hold 777766
Sell 000000
Strong Sell 000000
Total 777766

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stifel
Stifel
Hold
Maintains
$7$8
Hold Maintains $7$8 +0.76% Nov 6, 2024
Truist Securities
Truist Securities
Hold
Maintains
$7.5$6
Hold Maintains $7.5$6 -24.43% Oct 14, 2024
UBS
UBS
Hold
Maintains
$6.5$7
Hold Maintains $6.5$7 -11.84% Aug 7, 2024
Truist Securities
Truist Securities
Hold
Maintains
$9$7.5
Hold Maintains $9$7.5 -5.54% Aug 7, 2024
Truist Securities
Truist Securities
Hold
Maintains
$7$9
Hold Maintains $7$9 +13.35% Jul 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
211.72M
from 187.12M
Increased by 13.15%
Revenue Next Year
229.43M
from 211.72M
Increased by 8.36%
EPS This Year
-0.94
from -0.81
EPS Next Year
-0.77
from -0.94
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
39.42M57.37M94.42M141.84M187.12M211.72M229.43M251.29M
Revenue Growth
-45.54%64.59%50.22%31.92%13.15%8.36%9.53%
EPS
-0.13-0.12-0.43-0.77-0.81-0.94-0.77-0.69
EPS Growth
--------
Forward PE
--------
No. Analysts -----888
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 218.7M 239.1M 271.1M
Avg 211.7M 229.4M 251.3M
Low 202.9M 219.1M 234.8M

Revenue Growth

Revenue Growth 20242025202620272028
High
16.9%
12.9%
18.2%
Avg
13.1%
8.4%
9.5%
Low
8.4%
3.5%
2.3%

EPS Forecast

EPS 20242025202620272028
High -0.96 -0.74 -0.64
Avg -0.94 -0.77 -0.69
Low -0.94 -0.86 -0.74

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.